Lippis Daniel J.'s Form 4 filing
Edwards Lifesciences Corp (EW) · filed May 9, 2025
- Accession no.
- 0001225208-25-004947
- Filed
- May 9, 2025
- Trade date
- May 8-9, 2025
- Filing delay
- 1 day
- Rule 10b5-1 plan
- Checked
This filing lists 3 non-derivative transactions and 3 derivative transactions. Open-market sales total $24.6K. It was filed 1 day after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Lippis Daniel J.CIK 0002004380 | Officer (CVP, JAPAC) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| May 8, 2025 | Common Stock | AGrant or awardAcquired | +4,225 | $0.00 | $0 | 26,616.11 | Direct | |
| May 9, 2025 | Common Stock | MOption exerciseAcquired | +330 | $45.28 | +$14,942.4 | 26,946.11 | Direct | |
| May 9, 2025 | Common Stock | SSaleDisposed | −330 | $74.42 | −$24,558.6 | 26,616.11 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| May 8, 2025 | Common Stock | AGrant or awardAcquired | +21,500 | $0.00 | $0 | 21,500 | Direct | |
| May 8, 2025 | Common Stock | AGrant or awardAcquired | +4,225 | $0.00 | $0 | 4,225 | Direct | |
| May 9, 2025 | Common Stock | MOption exerciseDisposed | −330 | $0.00 | $0 | 0 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.